Amphastar Pharmaceuticals (AMPH) EBT Margin (2016 - 2025)
Historic EBT Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to 11.21%.
- Amphastar Pharmaceuticals' EBT Margin fell 137200.0% to 11.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.51%, marking a year-over-year decrease of 78200.0%. This contributed to the annual value of 26.66% for FY2024, which is 15700.0% down from last year.
- Per Amphastar Pharmaceuticals' latest filing, its EBT Margin stood at 11.21% for Q3 2025, which was down 137200.0% from 22.55% recorded in Q2 2025.
- In the past 5 years, Amphastar Pharmaceuticals' EBT Margin registered a high of 38.83% during Q4 2022, and its lowest value of 4.96% during Q1 2021.
- In the last 5 years, Amphastar Pharmaceuticals' EBT Margin had a median value of 23.97% in 2023 and averaged 23.42%.
- Per our database at Business Quant, Amphastar Pharmaceuticals' EBT Margin soared by 295000bps in 2021 and then tumbled by -147400bps in 2022.
- Amphastar Pharmaceuticals' EBT Margin (Quarter) stood at 22.47% in 2021, then surged by 73bps to 38.83% in 2022, then decreased by -25bps to 29.14% in 2023, then fell by -9bps to 26.47% in 2024, then plummeted by -58bps to 11.21% in 2025.
- Its last three reported values are 11.21% in Q3 2025, 22.55% for Q2 2025, and 18.1% during Q1 2025.